HOUSTON, June 25, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (FBLG), ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback